162 related articles for article (PubMed ID: 21421119)
21. Prognostic factors in prostate cancer.
Stattin P
Scand J Urol Nephrol Suppl; 1997; 185():1-46. PubMed ID: 9249905
[TBL] [Abstract][Full Text] [Related]
22. Radiation therapy for urologic malignancies in the elderly.
Sandhu A; Mundt AJ
Urol Oncol; 2009; 27(6):643-52. PubMed ID: 19879475
[TBL] [Abstract][Full Text] [Related]
23. Comparing a generic and individualized information decision support intervention for men newly diagnosed with localized prostate cancer.
Davison BJ; Goldenberg SL; Wiens KP; Gleave ME
Cancer Nurs; 2007; 30(5):E7-15. PubMed ID: 17876177
[TBL] [Abstract][Full Text] [Related]
24. American Cancer Society guideline for the early detection of prostate cancer: update 2010.
Wolf AM; Wender RC; Etzioni RB; Thompson IM; D'Amico AV; Volk RJ; Brooks DD; Dash C; Guessous I; Andrews K; DeSantis C; Smith RA;
CA Cancer J Clin; 2010; 60(2):70-98. PubMed ID: 20200110
[TBL] [Abstract][Full Text] [Related]
25. Assessment of prognosis with the total illness burden index for prostate cancer: aiding clinicians in treatment choice.
Litwin MS; Greenfield S; Elkin EP; Lubeck DP; Broering JM; Kaplan SH
Cancer; 2007 May; 109(9):1777-83. PubMed ID: 17354226
[TBL] [Abstract][Full Text] [Related]
26. Geriatric screening and preventive care.
Spalding MC; Sebesta SC
Am Fam Physician; 2008 Jul; 78(2):206-15. PubMed ID: 18697503
[TBL] [Abstract][Full Text] [Related]
27. Serum markers for prostate cancer: a rational approach to the literature.
Steuber T; O'Brien MF; Lilja H
Eur Urol; 2008 Jul; 54(1):31-40. PubMed ID: 18243505
[TBL] [Abstract][Full Text] [Related]
28. Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician.
Higano CS
Urol Clin North Am; 2004 May; 31(2):331-52. PubMed ID: 15123412
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and treatment of prostate cancer.
Naitoh J; Zeiner RL; Dekernion JB
Am Fam Physician; 1998 Apr; 57(7):1531-9, 1541-2, 1545-7. PubMed ID: 9556643
[TBL] [Abstract][Full Text] [Related]
30. Obesity and prostate cancer: epidemiology and clinical implications.
Buschemeyer WC; Freedland SJ
Eur Urol; 2007 Aug; 52(2):331-43. PubMed ID: 17507151
[TBL] [Abstract][Full Text] [Related]
31. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR;
Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313
[TBL] [Abstract][Full Text] [Related]
32. Regret in men treated for localized prostate cancer.
Hu JC; Kwan L; Saigal CS; Litwin MS
J Urol; 2003 Jun; 169(6):2279-83. PubMed ID: 12771770
[TBL] [Abstract][Full Text] [Related]
33. Management of localized prostate cancer in senior adults: the crucial role of comorbidity.
Fitzpatrick JM
BJU Int; 2008 Mar; 101 Suppl 2():16-22. PubMed ID: 18307688
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of prostate specific antigen testing for prostate cancer in elderly men.
Dyche DJ; Ness J; West M; Allareddy V; Konety BR
J Urol; 2006 Jun; 175(6):2078-82. PubMed ID: 16697807
[TBL] [Abstract][Full Text] [Related]
35. Critical review: is watchful waiting a viable management option for older men with prostate cancer?
Bailey DE; Wallace M
Am J Mens Health; 2007 Mar; 1(1):18-28. PubMed ID: 19482780
[TBL] [Abstract][Full Text] [Related]
36. Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adults.
Droz JP; Balducci L; Bolla M; Emberton M; Fitzpatrick JM; Joniau S; Kattan MW; Monfardini S; Moul JW; Naeim A; van Poppel H; Saad F; Sternberg CN
Crit Rev Oncol Hematol; 2010 Jan; 73(1):68-91. PubMed ID: 19836968
[TBL] [Abstract][Full Text] [Related]
37. Four prognostic indices in advanced prostate cancer patients, under palliative androgen deprivation treatment.
Bantis A; Zissimopoulos A; Kalaitzis C; Giannakopoulos S; Sountoulides P; Parmenopoulou V; Agelonidou E; Touloupidis S
Hell J Nucl Med; 2008; 11(1):21-5. PubMed ID: 18392222
[TBL] [Abstract][Full Text] [Related]
38. Should we treat localized prostate cancer? An opinion.
Menon M; Parulkar BG; Baker S
Urology; 1995 Nov; 46(5):607-16. PubMed ID: 7495109
[TBL] [Abstract][Full Text] [Related]
39. A model of prostate-specific antigen screening outcomes for low- to high-risk men: information to support informed choices.
Howard K; Barratt A; Mann GJ; Patel MI
Arch Intern Med; 2009 Sep; 169(17):1603-10. PubMed ID: 19786680
[TBL] [Abstract][Full Text] [Related]
40. Prostate Cancer in Elderly Men: Screening, Active Surveillance, and Definitive Therapy.
Roussel B; Ouellet GM; Mohile SG; Dale W
Clin Geriatr Med; 2015 Nov; 31(4):615-29. PubMed ID: 26476120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
